Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.
Kuter DJ, Mayer J, Efraim M, Bogdanov LH, Baker R, Kaplan Z, Garg M, Trněný M, Choi PY, Jansen AJG, McDonald V, Bird R, Gumulec J, Kostal M, Gernsheimer T, Ghanima W, Daak A, Cooper N. Kuter DJ, et al. Among authors: jansen ajg. Blood Adv. 2024 Apr 9;8(7):1715-1724. doi: 10.1182/bloodadvances.2023012044. Blood Adv. 2024. PMID: 38386978 Free PMC article. Clinical Trial.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, van den Bergh WM, Demandt AMP, Kerver ED, Jansen AJG, Westerweel PE, Arbous MS, Determann RM, van Mook WNKA, Koeman M, Mäkelburg ABU, van Lienden KP, Vlaar APJ, Biemond BJ. van Baarle FLF, et al. Among authors: jansen ajg. Am J Hematol. 2023 Nov;98(11):E305-E308. doi: 10.1002/ajh.27053. Epub 2023 Aug 21. Am J Hematol. 2023. PMID: 37605361 No abstract available.
Coagulation biomarkers for ischemic stroke.
Barakzie A, Jansen AJG, Ten Cate H, de Maat MPM. Barakzie A, et al. Among authors: jansen ajg. Res Pract Thromb Haemost. 2023 Apr 23;7(4):100160. doi: 10.1016/j.rpth.2023.100160. eCollection 2023 May. Res Pract Thromb Haemost. 2023. PMID: 37274178 Free PMC article.
Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.
van Baarle FLF, van de Weerdt EK, van der Velden WJFM, Ruiterkamp RA, Tuinman PR, Ypma PF, van den Bergh WM, Demandt AMP, Kerver ED, Jansen AJG, Westerweel PE, Arbous SM, Determann RM, van Mook WNKA, Koeman M, Mäkelburg ABU, van Lienden KP, Binnekade JM, Biemond BJ, Vlaar APJ. van Baarle FLF, et al. Among authors: jansen ajg. N Engl J Med. 2023 May 25;388(21):1956-1965. doi: 10.1056/NEJMoa2214322. N Engl J Med. 2023. PMID: 37224197 Clinical Trial.
Quantitative super-resolution imaging of platelet degranulation reveals differential release of von Willebrand factor and von Willebrand factor propeptide from alpha-granules.
Swinkels M, Hordijk S, Bürgisser PE, Slotman JA, Carter T, Leebeek FWG, Jansen AJG, Voorberg J, Bierings R. Swinkels M, et al. Among authors: jansen ajg. J Thromb Haemost. 2023 Jul;21(7):1967-1980. doi: 10.1016/j.jtha.2023.03.041. Epub 2023 Apr 13. J Thromb Haemost. 2023. PMID: 37061132 Free article.
Validity and reliability of Eforto®, a system to (self-)monitor grip strength and muscle fatigability in older persons.
De Dobbeleer L, Swart MM, Geerds MAJ, Baggen RJ, Jansen AS, Tielemans R, Silva H, Lieten S, Barbé K, Peeters G, Vollenbroek-Hutten MMR, Melis RJF, Bautmans I. De Dobbeleer L, et al. Aging Clin Exp Res. 2023 Apr;35(4):835-845. doi: 10.1007/s40520-023-02365-3. Epub 2023 Mar 10. Aging Clin Exp Res. 2023. PMID: 36897558 Free PMC article.
Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis.
Horjus J, van Mourik-Banda T, Heerings MAP, Hakobjan M, De Witte W, Heersema DJ, Jansen AJ, Strijbis EMM, de Jong BA, Slettenaar AEJ, Zeinstra EMPE, Hoogervorst ELJ, Franke B, Kruijer W, Jongen PJ, Visser LJ, Poelmans G. Horjus J, et al. Among authors: jansen aj. Int J Mol Sci. 2022 Sep 28;23(19):11461. doi: 10.3390/ijms231911461. Int J Mol Sci. 2022. PMID: 36232761 Free PMC article.
66 results